Who is sponsoring NCT04243980?

NCT04243980 is sponsored by HaEmek Medical Center, Israel.

What drugs are being tested in NCT04243980?

Interventions in NCT04243980: Short anatomical femoral stem in THR.

What condition does NCT04243980 study?

NCT04243980 studies Patient Compliance, Patient Satisfaction.

Is NCT04243980 still recruiting?

NCT04243980 is currently status unknown. Last updated 28 January 2020.

Last reviewed 2020-01-28 · How we verify

NCT04243980: THR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anatomical Femoral Stem in Total Hip Arthroplasty

Status unknown Last updated 28 January 2020

What this trial tests

trial testing Short anatomical femoral stem in THR in Patient Compliance in 50 participants. Status unknown.

Timeline

1 February 2020

Primary endpoint
1 January 2021

1 January 2022

Quick facts

Lead sponsor	HaEmek Medical Center, Israel
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 February 2020
Primary completion	1 January 2021
Estimated completion	1 January 2022

Drugs / interventions tested

Short anatomical femoral stem in THR

Conditions studied

Patient Compliance — all drugs for Patient Compliance →
Patient Satisfaction — all drugs for Patient Satisfaction →

Sponsor

HaEmek Medical Center, Israel

Who can join

Adults 18 to 90, any sex, with Patient Compliance or Patient Satisfaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study that detect the femoral anteversion after total hip arthroplasty using short anatomical femoral stem compared to the contrast side

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Successful reconstruction of natural femoral anteversion using a short femoral stem in total hip arthroplasty surgery.
Hakim R, Weinstein A, Dabby D, Rozen N, et al · · 2022 · cited 1× · PMID 35443831 · DOI 10.1177/03000605221091500

Verify or expand the search:

Other recruiting trials for Patient Compliance

Currently open trials in the same condition.

NCT04656028 — Genetic Testing and Motivational Counseling for FH · NA · active not recruiting
NCT06076512 — Pain Clinic Provides Public Health Safety · recruiting

Other HaEmek Medical Center, Israel trials

Trials by the same sponsor.

NCT06656286 — Hysteroscopic Intrauterine Suturing · NA · not yet recruiting
NCT06803992 — Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter · Phase 4 · recruiting
NCT06542367 — Trans Canal Tympanoplasty With Local Anesthesia Using Fat Graft and "TachoSil" · NA · not yet recruiting
NCT05732155 — Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury. · Phase 2 · unknown
NCT05933018 — Night Hyperglycemia and Fatty Liver in Type 1 Diabetes · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04243980 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by HaEmek Medical Center, Israel
Last refreshed: 28 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04243980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing